Skip to main content

Morning Movers: Eli Lilly rises, Boston Scientific falls after quarterly results

Tipranks - Thu Feb 5, 8:02AM CST

Stock futures are mixed and have shown modest signs of stabilization after a sharp downturn in software and AI-related technology stocks yesterday, prompting some investors to treat the technology selloff that pressured equities broadly as a buying opportunity. Against that backdrop, defensive sectors and commodity-linked assets have drawn interest, particularly as gold reclaimed levels above $5,000 an ounce, reflecting continued demand for safe havens amid uncertainty.

Claim 50% Off TipRanks Premium

In pre-market trading, S&P 500 futures rose 0.11%, Nasdaq futures fell 0.34% and Dow futures rose 0.22%.

Check out this morning’s top movers from around Wall Street, compiled by The Fly. 

HIGHER –

  • Silicon Labs (SLAB) up 49% after signing a definitive agreement under which Texas Instruments (TXN) will acquire the company for $231 per share in an all-cash transaction


UP AFTER EARNINGS –

  • Eli Lilly (LLY) up 9%
  • Johnson Controls (JCI) up 5%
  • GE HealthCare (GEHC) up 5%
  • Fox Corp. (FOXA) up 2%
  • Equifax (EFX) down 1%
  • Fortive (FTV) up 1%

DOWN AFTER EARNINGS –

  • AMD (AMD) down 10%
  • Boston Scientific (BSX) down 9%
  • Chipotle (CMG) down 4%
  • AbbVie (ABBV) down 2%
  • Uber (UBER) down 2%
  • Cognizant (CTSH) down 2%
  • Yum! Brands (YUM) down 1%


LOWER –

  • Texas Instruments (TXN) down 3% after entering a definitive agreement to acquire Silicon Labs (SLAB)

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.